A well-tolerated rAAV vector-mediated gene therapy in normotensive Brown Norway rats is used to reduce intraocular pressure in a dose dependent manner, encouraging further evaluations on pre-clinical models of glaucoma.
- Kristina J. Chern
- Emily R. Nettesheim
- Daniel M. Lipinski